BrainCo operates across non-invasive EEG products, attention training, neurorehabilitation and prosthetic hands. The financing can support research, medical-device registration, manufacturing and distribution, while increasing expectations for revenue growth and product delivery.
The public report did not identify a lead investor, provide a complete investor list or disclose the post-money valuation. The size of the round measures capital committed, not product effectiveness, regulatory approval or commercial revenue.